Effect of clinician information sessions on diagnostic testing for Chagas disease.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
26
08
2021
accepted:
20
05
2022
revised:
29
06
2022
pubmed:
17
6
2022
medline:
2
7
2022
entrez:
16
6
2022
Statut:
epublish
Résumé
Chagas disease is a potentially life-threatening neglected disease of poverty that is endemic in continental Latin America. Caused by Trypanosoma cruzi (T. cruzi), it is one of six parasitic diseases in the United States targeted by the Centers for Disease Control as a public health problem in need of action. An estimated 300,000 people are infected with T. cruzi in the United States (US). Although its morbidity, mortality and economic burden are high, awareness of Chagas disease is lacking among many healthcare providers in the US. The purpose of this analysis is to determine if the number of diagnostic tests performed at a community health center serving an at-risk population for Chagas disease increased after information sessions. A secondary aim was to determine if there was a difference by provider type, i.e., nurse practitioner vs. physician, or by specialty in the number of patients screened. We conducted a retrospective data analysis of the number of Chagas serology tests performed at a community health center before and after information sessions for clinicians. A time series analysis was conducted focusing on the Adult and Family Medicine Departments at East Boston Neighborhood Health Center (EBNHC). Across all departments there were 1,957 T. cruzi tests performed before the sessions vs. 2,623 after the sessions. Interrupted time series analysis across departments indicated that testing volume was stable over time prior to the sessions (pre-period slope = +4.1 per month; p = 0.12), followed by an immediate shift after the session (+51.6; p = 0.03), while testing volume remained stable over time after the session (post-period slope = -6.0 per month; p = 0.11). In this study, Chagas testing increased after information sessions. Clinicians who began testing their patients for Chagas disease after learning of the importance of this intervention added an extra, potentially time-consuming task to their already busy workdays without external incentives or recognition.
Sections du résumé
BACKGROUND
Chagas disease is a potentially life-threatening neglected disease of poverty that is endemic in continental Latin America. Caused by Trypanosoma cruzi (T. cruzi), it is one of six parasitic diseases in the United States targeted by the Centers for Disease Control as a public health problem in need of action. An estimated 300,000 people are infected with T. cruzi in the United States (US). Although its morbidity, mortality and economic burden are high, awareness of Chagas disease is lacking among many healthcare providers in the US. The purpose of this analysis is to determine if the number of diagnostic tests performed at a community health center serving an at-risk population for Chagas disease increased after information sessions. A secondary aim was to determine if there was a difference by provider type, i.e., nurse practitioner vs. physician, or by specialty in the number of patients screened.
METHODOLOGY/PRINCIPAL FINDINGS
We conducted a retrospective data analysis of the number of Chagas serology tests performed at a community health center before and after information sessions for clinicians. A time series analysis was conducted focusing on the Adult and Family Medicine Departments at East Boston Neighborhood Health Center (EBNHC). Across all departments there were 1,957 T. cruzi tests performed before the sessions vs. 2,623 after the sessions. Interrupted time series analysis across departments indicated that testing volume was stable over time prior to the sessions (pre-period slope = +4.1 per month; p = 0.12), followed by an immediate shift after the session (+51.6; p = 0.03), while testing volume remained stable over time after the session (post-period slope = -6.0 per month; p = 0.11).
CONCLUSION/SIGNIFICANCE
In this study, Chagas testing increased after information sessions. Clinicians who began testing their patients for Chagas disease after learning of the importance of this intervention added an extra, potentially time-consuming task to their already busy workdays without external incentives or recognition.
Identifiants
pubmed: 35709253
doi: 10.1371/journal.pntd.0010524
pii: PNTD-D-21-01268
pmc: PMC9242495
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010524Subventions
Organisme : NLM NIH HHS
ID : G08 LM013191
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS Negl Trop Dis. 2016 Nov 7;10(11):e0005033
pubmed: 27820837
Am J Trop Med Hyg. 2015 Jul;93(1):108-13
pubmed: 25986581
J Racial Ethn Health Disparities. 2017 Jun;4(3):523-528
pubmed: 27324820
PLoS Negl Trop Dis. 2016 Mar 14;10(3):e0004508
pubmed: 26974551
Emerg Infect Dis. 2010 May;16(5):871-2
pubmed: 20409389
Race Soc Probl. 2012 Apr;4(1):
pubmed: 24307918
Transpl Infect Dis. 2016 Nov 14;19(1):e12633
pubmed: 27862705
Curr Opin Infect Dis. 2018 Oct;31(5):415-421
pubmed: 30095485
Ann Oncol. 2019 Jul 1;30(7):1162-1169
pubmed: 30937431
Am J Public Health. 2012 Jul;102(7):1250-4
pubmed: 22594736
PLoS Negl Trop Dis. 2021 Dec 17;15(12):e0010043
pubmed: 34919556
Otolaryngol Clin North Am. 2021 Feb;54(1):239-245
pubmed: 33153740
Clin Infect Dis. 2009 Sep 1;49(5):e52-4
pubmed: 19640226
Pediatr Infect Dis J. 2018 Jan;37(1):e24-e27
pubmed: 28777208
J Health Care Poor Underserved. 2012 May;23(2):651-65
pubmed: 22643614
PLoS One. 2021 Feb 26;16(2):e0246783
pubmed: 33635887
Curr Treat Options Infect Dis. 2018;10(3):373-388
pubmed: 30220883
J Cancer. 2020 Aug 15;11(20):5953-5970
pubmed: 32922537
Am J Trop Med Hyg. 2010 Oct;83(4):891-5
pubmed: 20889886
Soc Sci Med. 2011 Aug;73(4):586-594
pubmed: 21778008
Can Fam Physician. 2021 Jan;67(1):13-14
pubmed: 33483387
PLoS Negl Trop Dis. 2009 Jul 07;3(7):e484
pubmed: 19582163
Lancet. 2020 Apr 11;395(10231):1194
pubmed: 32246915
J Health Econ. 2013 Dec;32(6):1105-16
pubmed: 24135614
J Immigr Minor Health. 2017 Jun;19(3):702-708
pubmed: 27041120
PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004343
pubmed: 26913759
Health Policy Plan. 2013 May;28(3):320-7
pubmed: 22763126
Soc Sci Med. 2017 Apr;179:147-159
pubmed: 28279924
JAMA. 2007 Nov 14;298(18):2171-81
pubmed: 18000201
Ann Fam Med. 2016 May;14(3):267-9
pubmed: 27184998
Trans R Soc Trop Med Hyg. 2014 Jul;108(7):388-90
pubmed: 24771504
Rev Esp Cardiol. 2007 Mar;60(3):285-93
pubmed: 17394874
PLoS Negl Trop Dis. 2019 Sep 26;13(9):e0007447
pubmed: 31557155
J Clin Microbiol. 2021 Nov 18;59(12):e0106221
pubmed: 34469183
Clin Infect Dis. 2017 May 1;64(9):1182-1188
pubmed: 28329123
Soc Sci Med. 2014 Feb;103:7-14
pubmed: 24507906
J Health Soc Behav. 2018 Dec;59(4):466-485
pubmed: 30484715
Matern Child Health J. 2008 May;12(3):283-6
pubmed: 17602289
Health Serv Res. 2015 Dec;50 Suppl 2:2057-89
pubmed: 26549041
Am J Bioeth. 2021 Feb;21(2):19-27
pubmed: 33280534
Eur J Cancer. 2020 Mar;127:207-223
pubmed: 31980322
N Engl J Med. 2015 Oct;373(14):1295-306
pubmed: 26323937
Nurse Educ Today. 2018 Feb;61:249-257
pubmed: 29272824
Lancet Infect Dis. 2013 Apr;13(4):342-8
pubmed: 23395248
MMWR Morb Mortal Wkly Rep. 2018 Jul 06;67(26):738-741
pubmed: 29975678